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HuR controls apoptosis and activation response without effects on cytokine 3’ UTRs
Fedor V. Karginov
Department of Molecular, Cell, and Systems Biology, Institute for Integrative Genome Biology, University of California, Riverside, CA, USA
ABSTRACT
RNA binding proteins regulate gene expression through several post-transcriptional mechanisms. The
broadly expressed HuR/ELAVL1 is important for proper function of multiple immune cell types, and has
been proposed to regulate cytokine and other mRNA 3′ UTRs upon activation. However, this mechanism
has not been previously dissected in stable cellular settings. In this study, HuR demonstrated strong anti-
apoptotic and activation roles in Jurkat T cells. Detailed transcriptomic analysis of HuR knockout cells
revealed a substantial negative impact on the activation program, coordinately preventing the expres-
sion of immune response gene categories, including all cytokines. Knockout cells showed a significant
defect in IL-2 production, which was rescued upon reintroduction of HuR. Interestingly, the mechanism
of HuR regulation did not involve control of the cytokine 3′ UTRs: HuR knockout did not affect the
activity of 3′ UTR reporters in 293 cells, and had no effect on IL-2 and TNF 3′ UTRs in resting or activated
Jurkats. Instead, impaired cytokine production corresponded with defective induction of the IL-2
promoter upon activation. Accordingly, upregulation of NFATC1 was also impaired, without 3′ UTR
effects. Together, these results indicate that HuR controls cytokine production through coordinated
upstream pathways, and that additional mechanisms must be considered in investigating its function.
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Introduction
HuR/ELAVL1 is an abundant and ubiquitously expressed
RNA binding protein (RBP) that is essential for many devel-
opmental and homeostatic processes. HuR knockout (KO)
mice die in embryogenesis, where HuR is necessary for pla-
cental, skeletal and splenic development [1]. Postnatal dele-
tion of HuR causes depletion of bone marrow, thymic, and
intestinal progenitor cells through apoptosis [2]. Similarly,
HuR is necessary for neuronal survival [3,4] and in sperma-
togenesis [5], and is upregulated in many cancers [6,7]. In the
immune system, HuR is required for thymocyte maturation
and exit to the periphery [8], for T cell proliferation and
migration [9–11], and for B cell antibody response [12,13];
HuR deletion and overexpression impacts inflammatory
responses in vivo [14,15].
The dynamic control of cytokine and other mRNAs upon
activation of immune cells has been closely examined both at the
transcriptional and post-transcriptional level. Their transcrip-
tion is robustly induced by the NFATC homologs and other
factors [16,17], best characterized at the interleukin (IL)-2 pro-
moter. In addition, IL-2, tumor necrosis factor (TNF), interferon
(IFN)-gamma, colony stimulating factor 2 (CSF2) and other
mRNAs are extremely labile in resting cells, and are strongly
post-transcriptionally stabilized after stimulation [18]. The
destabilization is caused by a group of RBPs (AUF1/HNRNPD,
TTP/ZFP36 and others) that bind to ‘class II’ AU-rich elements
(AREs) – tandem copies of AUUUA – found in many cytokine
mRNA 3′ UTRs [19,20].
Several lines of evidence have led to a model where HuR
stabilizes cytokine mRNAs through interactions with the 3′
UTR AREs [reviewed in 20–22]. HuR is induced in T cells
upon activation, translocates from the nucleus to the cyto-
plasm, and binds to the ARE regions of many cytokine
mRNAs. Overexpression of HuR has been shown to upregu-
late 3′ UTR reporters and to increase the half-life of ARE-
containing mRNAs. Thus, HuR has been proposed to posi-
tively affect mRNA stability by competing with the destabiliz-
ing RBPs mentioned above for binding at the ARE sites. An
alternative model for these observations is that HuR promotes
decay, but its overexpression titrates away necessary complex
components, resulting in protection [22]. However, these and
other molecular mechanisms of cytokine mRNA control, as
well as HuR’s overall cellular roles, have not been examined in
KO T cell line models.
In the context of mouse models, the effects of HuR on
cytokine production vary greatly, likely due to the complex
in vivo physiological feedback, developmental transitions, and
timing of the HuR deletion. Upon conditional knockout of
HuR in late-stage thymocytes, activated peripheral CD4+
T cells showed transcriptionally elevated IL-2 levels, but sub-
stantially reduced IL-4, IL-5, and IL-13 [10]. In another
model, conditional HuR KOs in activated T cells, after Th2
polarization, exhibited transcriptional upregulation of IL-4
and increased IL-2 and IL-13 mRNA stability [23]. Th17
polarization of the same knockouts resulted in decreased IL-
17 mRNA stability and protein levels [9]. HuR deletion in
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early thymocytes did not change IL-3 mRNA levels, and
increased those of TNF [8]. Finally, in an inducible mouse
overexpression model, upregulation of HuR in macrophages
increased TNF mRNA stability, but strongly downregulated
its translation [14]. Thus, while animal models are undoubt-
edly necessary to examine the relevant biological roles of
HuR, they provide fewer avenues in deciphering its direct
molecular functions.
Like many other RBPs, HuR has been implicated in post-
transcriptional control of gene expression through several
mechanisms, and their relative importance in regulating
each target is mostly unknown. Aside from roles in 3′ UTR
control, HuR is strongly associated with splicing: a major
portion of HuR binding sites determined by CLIP-seq are
intronic, found near splice sites, show sequence conservation,
and affect expression of the target gene [24,25]. Alternative
splicing of hundreds of mRNAs is suggested to facilitate
HuR’s role in ensuring a proper B cell response [12]. HuR
also downregulates inclusion of Fas mRNA exon 6, and con-
trols alternative splicing of Eif4enif1 [26,27]. Furthermore,
positive and negative effects of HuR on translation have
been identified [14,28–31], and HuR has been shown to
impact alternative polyadenylation [32,33].
In this study, the cellular role and molecular mechanism of
HuR function was addressed using stable KO cell line models.
HuR prevents apoptosis and establishes an activated expres-
sion program in Jurkat cells; interestingly, it does so without
regulating cytokine expression through the 3′ UTR, coordi-
nately controlling upstream transcriptional events instead.
Results
HuR KO Jurkat cells exhibit a strong apoptotic phenotype
The RNA-binding protein HuR is important for multiple
aspects of T cell development and activation, and several
specific functions, molecular modes of action, as well as
many targeted mRNAs have been identified. To examine its
cellular roles and molecular mechanism in a T cell setting in
detail, a CRISPR/Cas9-mediated HuR KO model was created
in Jurkat cells. Following transient sgRNA/Cas9 plasmid
transfection and clonal screening by dot immunoblot, two
clones (generated with independent sgRNAs targeting HuR
exons 5 and 3) were identified, and validated by western blot
to completely lack HuR protein (Figure 1(a)). The use of two
targeting sites ensures lack of common off-target mutations
between the clones that can complicate phenotypic analysis.
The resulting cell lines propagated slower than the parental
WT, and had a substantial fraction of blebbing, apoptotic cells
(Figure S1(a)). These cells resembled the apoptotic process
induced in WT Jurkats by staurosporine (Figure S1A). The
apoptotic phenotype was reproducibly confirmed by Annexin
V/7AAD staining and flow cytometry (Figure 1(b)), with the
knockout lines demonstrating 2.5–4.9 fold higher percentages
of cell death (Figure 1(c)). Thus, deletion of HuR in two
independent Jurkat clones resulted in substantially higher
apoptosis. Extended passage of the KO lines diminished the
apoptotic phenotype, indicating ongoing adaptation/selection
in the clonal cell lines (Figure S2). In addition to cell death,
a smaller fraction of large, multinucleated cells was observed
in the populations (Figure S1(a) and Figure S3). For the non-
apoptotic KO cells, phase-contrast microscopy and staining of
the actin cytoskeleton with phalloidin, along with a nuclear
7AAD stain, revealed an otherwise normal size and morphol-
ogy (Figure S1 and Figure S3).
HuR controls the expression of a large set of mRNAs
In T cells, HuR is known to bind to a large set of mRNAs
[34,35], and to control mRNA fates during the activation
program [36]. To elucidate the global and specific effects of
HuR on mRNA expression as a function of activation, RNA-
Seq measurements were carried out in WT and HUR KO1 cells
in resting and PMA/ionomycin-activated states, allowing for
multiple pairwise comparisons between the datasets. Consistent
with the expected substantial changes in gene expression upon
activation, the largest differences between the resulting four
groups of samples were attributable to the activation state by
principal component analysis (PC1, Figure S4(a)) and hierarch-
ical clustering (Figure S4(b)), while the three biological repli-
cates in each group showed high reproducibility. Interestingly,
the second principal component, accounting for 26% of the
variance, corresponded to presence of HuR, with particularly
significant differences in the activated state (Figure S4(a)). This
separation indicated that HuR controls the levels of a large set
of mRNAs in Jurkat cells. Accordingly, differential expression
(DE) analysis with stringent cutoffs (4-fold change and 5%
Figure 1. Generation and apoptosis phenotype of HuR KO Jurkat cells. (a)
Western blot of a HuR-positive clone isolated during KO generation, along
with two independent KO clones. (b) Representative measurement of WT and
HuR KO apoptosis rates by Annexin V and 7AAD staining, followed by flow
cytometry. (c) Relative apoptosis of early-passage HuR KO1 and KO2 clones,
n = 4. WT Jurkat cell cultures contained 7.4 ± 1.7% apoptotic cells. Error bars
represent standard error of the mean. *, p-value < 0.05, paired two-tailed
Student’s t test of apoptotic percentages between WT and KO.
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FDR) identified 553 DE genes in resting KO vs WT cells, and
1398 DE genes in activated KO vs WT cells (Figure 2(a)).
Notably, these gene sets contained considerably more mRNAs
that are upregulated, rather than decreased, in the KO.
Together, these observations demonstrate that HuR is a broad
post-transcriptional regulatory factor that substantially impacts
the gene expression program.
Hur controls a major portion of the activation response
Activation of T cells upon antigen encounter elicits a massive
transformation in gene expression leading to changes in pro-
liferation state, morphology, and other characteristics. To assess
the involvement of HuR in the activation program, the DE
gene sets were examined in detail. As reported above, stimula-
tion of WT Jurkat cells caused extensive expression changes,
mostly in the direction of upregulation (Figure 2(a,b)).
Strikingly, this activation response was largely negated or pre-
vented in the absence of HuR: genes that were upregulated
upon activation in WT cells were significantly downregulated
in the activated KO vs WT comparison; conversely, genes that
were repressed upon WT cell activation were significantly
higher in KO vs WT activated cells (Figure 2(b)). The substan-
tial overlap between genes impacted by cell stimulation and
HuR KO, and their opposing directions of change (Figure 2(c)),
indicates involvement of HuR in establishing the activated
expression program. Examination of the gene ontology (GO)
category enrichment of the DE gene sets provided further
insight into the role of HuR in the reprogramming.
Stimulation of WT cells upregulated genes involved in immune
responses, including chemotaxis and production/secretion of
cytokines, as well as their regulatory factors (Figure 2(d), first
column). Remarkably, nearly all of these categories were also
enriched in genes that were downregulated in activated KO vs
WT cells (Figure 2(d), fourth column). Additionally, genes that
positively regulate cytokine production were downregulated in
HuR KO cells. In summary, HuR is responsible for enacting
a major part of the gene expression changes upon activation in
Jurkat cells.
HuR is necessary for cytokine production upon activation
Cytokine production is a key consequence of T cell activation.
Prompted by the GO enrichment results, expression of
Figure 2. Profiling of mRNA levels in resting vs. activated, WT vs. HuR KO1 cells (n = 3) reveals a substantial defect in the activation program of HuR KOs. (a) Number
of differentially expressed (upregulated and downregulated) genes passing a 4-fold change and 5% false discovery rate (FDR) cutoff, comparing the indicated sample
groups. (b) Heatmap of mRNA level changes for differentially expressed genes in WT cells between activated and resting states (left), and in the activated state
between KO and WT cells (right). (c) Overlap between genes upregulated upon activation in WT cells, and those downregulated in KO relative to WT in activated
cells. (d) clusterProfiler analysis of Gene Ontology category enrichment in upregulated and downregulated mRNA sets defined by the comparisons indicated at the
bottom.
688 F. V. KARGINOV
cytokine mRNAs was investigated in HuR KO Jurkat cells.
Comparing activated KO to WT cells, RNA-seq data showed
a strong reduction of levels for practically all cytokines that
are induced by stimulation in this cell line (Figure 3(a)),
ranging from 11-fold (IL-13) to 259-fold (IL-2) downregula-
tion. To validate the mRNA expression data, secreted IL-2
levels after 24 hours of PMA/ionomycin activation were mea-
sured by ELISA (Figure 3(b)). Again, the robust activation
seen in WT cells was diminished 45-fold in HuR KO1, con-
firming the RNA-seq results. Furthermore, IL-2 production in
the independently derived HuR KO2 was also 15-fold attenu-
ated relative to WT, demonstrating that the phenotype was
not a consequence of off-target mutations or clonal differ-
ences. It should be noted that the KO cells still underwent
morphological changes upon stimulation (rounding up), sug-
gesting that PMA/PKC-mediated aspects of the activation
program are intact (Figure S1(b)). Next, HuR’s role in cyto-
kine production was definitively addressed with a rescue
experiment. HuR KO1 cells were transduced with
a retroviral vector encoding HuR (along with an empty vector
control), stable integrant populations were selected, and
expression of HuR was confirmed (Figure S5). Measurement
of secreted IL-2 levels showed robust rescue of this cytokine’s
production upon reintroduction of HuR (Figure 3(c)).
Overall, these results establish that HuR is essential for cyto-
kine expression upon activation in Jurkat cells.
HuR does not significantly regulate cytokine mRNA 3′
UTRs in Jurkat and 293 cells
Early studies implicated HuR, along with other ARE-binding
proteins, in interactions with the 3′ UTRs of several cytokine
mRNAs or their fragments, including IL-2, IL-3, IL-13,
CSF2/GMCSF, TNF [37–45]. Overexpression of HuR caused
stabilization of CSF2, TNF and IL-13 3′ UTR or IL-3 mRNA-
containing reporters [43,44,46,47], and recombinant HuR
prevented degradation of TNF ARE RNA in an in vitro
assay [42], leading to a model of post-transcriptional
mRNA stabilization by binding their 3′ UTRs and competing
with other, destabilizing factors. The established knockout
cell lines provide a stable system to examine this and other
regulatory mechanisms mediating HuR’s role in mRNA
expression. To evaluate HuR’s effect on cytokine expression
through their 3′ UTRs, full-length UTR sequences were
cloned into a dual-luciferase reporter vector. Initially,
a panel of six cytokine UTRs was screened in the easily
transfectable human embryonic kidney T-REx-293 cells and
a derived HuR KO cell line [48]. Previously, we have demon-
strated a significant, albeit mild, regulation of an AUUUA-
containing reporter by HuR using these lines [49]. Relative
to empty vector controls, all of the constructs showed sub-
stantial downregulation in T-REx-293 cells, ranging from
2.4-fold (IL-3) to 30-fold (TNF), consistent with the known
destabilizing role of the UTRs (Figure 4(a)). Strikingly,
reporter activity in the absence of HuR was not statistically
significantly decreased for any of the UTRs. These results
indicate that HuR does not directly or indirectly regulate the
tested cytokine 3′ UTRs in 293 cells. Next, activity of the IL-2
and TNF 3′ UTR reporters was tested in resting and acti-
vated Jurkat cells, as well as HuR KO derivatives. Both
reporters showed substantial repression relative to empty
vector controls in resting WT Jurkats, and were de-
repressed to varying extents upon activation (Figure 4(b)),
confirming the previously known activities of these UTRs.
However, deletion of HuR in two independent clones did not
show consistent differences from WT for the IL-2 UTR, and
demonstrated small, statistically insignificant further repres-
sion of the TNF UTR. Notably, de-repression of the IL-2
UTR upon activation was still observed in HuR KO cells
(Figure 4(b)), indicating that HuR is dispensable for stabili-
zation of the reporter. Altogether, HuR does not substan-
tially participate in post-transcriptional regulation of the
tested cytokine UTRs in Jurkat or 293 cells.
HuR controls NFATC1 levels and IL-2 promoter activity
upon activation
Upon activation, T cell cytokine production is upregulated
and maintained by transcriptional and post-transcriptional
mechanisms. Since HuR affected cytokine levels, but post-
transcriptional control through the 3′ UTR was minimal,
transcriptional pathways were examined. Stimulation-
Figure 3. HuR regulates cytokine production in Jurkat cells. (a) RNAseq mRNA level log2 fold changes (FC) of expressed cytokines in activated KO1 vs. WT Jurkat cells.
(b) Secreted IL-2 levels in WT and HuR KO cells after stimulation with PMA/ionomycin, n = 3. (c) Rescue of IL-2 production in HuR KO1 cells transduced with MSCV-
MPIG-HuR retrovirus, compared to empty vector retrovirus, n = 3. Error bars represent standard error of the mean. *, p-value < 0.05, paired two-tailed Student’s t test
of normalized ELISA spectrometry measurements.
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induced activation of the IL-2 promoter is one of the most
characterized features of T cell activation [50]. Accordingly,
activity of a murine IL-2 promoter luciferase reporter [51] was
tested in WT and HuR KO Jurkat cells. As expected, activa-
tion of WT cells elicited a robust IL-2 transcriptional response
(Figure 5(a)). Interestingly, this response was strongly dimin-
ished in the absence of HuR, with 26-fold reduction in KO1
cells, and 2.7-fold decrease in KO2 cells. The reduced activity
indicates that HuR is necessary for IL-2 mRNA transcription
in Jurkat cells, and explains the impaired endogenous IL-2
secretion in HuR KO cells.
The coordinated attenuation of all expressed cytokines in
KO cells suggested that HuR may affect their expression
through a common upstream factor, since HuR itself does
not have appreciable DNA binding activity [52]. The
NFATC1/C2 transcription factors are master regulators of
cytokine production upon activation [53,54], and their levels
were investigated next. Upon stimulation, NFATC2 protein is
activated by dephosphorylation and nuclear import, while
NFATC1 mRNA transcription is also turned on in an auto-
regulatory loop. NFATC2 showed a mild (1.6-fold) but sig-
nificant upregulation in the RNA-seq mRNA levels in
activated KO vs WT cells, but NFATC1 demonstrated
a strong, 5.1-fold downregulation, suggesting that HuR may
regulate NFATC1 expression. When tested by Western blot,
NFATC1 levels were substantially (4.2-fold) increased upon
stimulation in WT cells, and this induction was significantly
reduced in HuR KO cells (Figure 5(b,c)). Thus, HuR affects
the accumulation of the induced NFATC1 transcription factor
upon activation in Jurkat cells. Finally, regulation of the
NFATC1 3′ UTR by HuR was examined. NFATC1 is tran-
scribed in two UTR isoforms, where the shorter UTR is
associated with NFATC1 induction. Interestingly, when both
isoforms were tested in luciferase assays in activated Jurkat
cells, the presence or absence of HuR had no statistically
significant effect on activity (Figure 5(d)), indicating that
HuR does not impact NFATC1 expression through its
3′ UTR.
Discussion
HuR is necessary for many biological processes, and has been
found to act through several molecular mechanisms. In this
study, knockout cell lines were used as defined, tractable
models to characterize its cellular roles, and perhaps more
importantly, its mechanisms of action. Two independent KO
lines in Jurkat cells demonstrated increased cell death and
defective activation phenotypes (Figures 1 and 3). The anti-
apoptotic role of HuR is consistent with its regulation of
apoptosis/survival-relevant transcripts [55], as well as results
from mouse KO models: deletion of HuR shows increased
apoptosis in placental development [1] and mature neurons
[4]. Additionally, recent studies in pancreatic cancer cell lines
indicated that HuR knockdown reduces proliferation and
migration [56], and HuR KO leads to apoptosis and abrogates
xenograft tumor growth [57]. The significance of the observed
phenotypes is also in line with the large number of mRNAs
bound by HuR in T cells [34]. Accordingly, stable elimination
of HuR in Jurkat cells lead to profound differences in the
mRNA expression profile, comparable in extent to the
changes due to stimulation (Figure 2(a)). The higher number
of upregulated (compared to downregulated) genes upon HuR
KO, both in resting and activated states, suggests that HuR
may carry an underappreciated repressive function for many
mRNAs, or it indirectly affects mRNA levels through other
factors. In this regard, most of the indirect changes are not
likely to be mediated by several known post-transcriptional
factors, since their levels are largely unperturbed in the RNA-
seq data (Supplementary Table 1).
Strikingly, many of the genes affected by activation in WT
cells were also differentially expressed, but with the opposite
direction of change, in the HuR KO vs WT comparison in the
activated state (Figure 2(b, c)). In other words, the activation
expression program is in large part controlled by HuR, and
does not properly ensue in its absence. Stimulation-induced
genes involved in cytokine secretion and its regulation, as well
as inflammatory/defensive responses and chemotaxis, are
among the transcripts that fail to be upregulated in HuR KO
cells (Figure 2(d)). The lack of upregulation was particularly
noticed for the cytokines themselves (Figure 3(a)).
Confirming the mRNA level observations, IL-2 secretion was
severely disrupted in HuR KO Jurkat cells, and rescued by
reintroduction of HuR (Figure 3(b,c)).
Early studies pointed to a positive role for HuR in cytokine
control, in general agreement with the observed defect in
cytokine expression signatures and the IL-2 production
Figure 4. HuR does not regulate IL-2 and TNF levels through their 3′ UTR. (a)
Activity of luciferase reporters containing cytokine mRNA 3′ UTRs measured in
WT and HuR KO T-REx-293 cells, n = 2. (b) Activity of IL-2 and TNF 3′ UTR
reporters in WT, HuR KO1 and HuR KO2 Jurkat cells in resting and activated
states, n = 3. Renilla luciferase activity was normalized to co-expressed firefly
luciferase activity and to empty (no 3′ UTR) control reporters.
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phenotype in HuR KO Jurkat cells (Figures 2 and 3).
However, the regulatory mechanism in Jurkat and 293 cells
is a surprise that is inconsistent with some of the previous
data: HuR does not appreciably regulate the 3′ UTRs of CSF2,
IFNG, IL-2, IL-3, IL-13, and TNF mRNAs in 293 cells, and
the major IL-2 and TNF cytokine mRNAs in Jurkats.
Previously, HuR was shown to bind AU-rich sequences in
TNF, CSF2 and IL-3 UTRs [38–43,45,58] and HuR immuno-
precipitation was shown to enrich IL-2, IL-13, INFg, and TNF
mRNA from lysates relative to IgG controls [8,35,44,59,60].
Together with reporter data demonstrating that overexpres-
sion of HuR causes stabilization of TNF, IL-13, and CSF2
UTR fragment or IL-3 whole mRNA reporters [43,44,46,47],
these observations generated a prevailing model that HuR
regulates mRNA stability through the 3′ UTR. HuR has also
been shown to bind and/or stabilize several other mRNAs
[28,61–64]. It should be noted that the majority of the earlier
studies necessarily used overexpression as a means of mod-
ulating HuR levels, and its effect on 3′ UTR reporter assays
may be more difficult to interpret than a knockout state.
Nevertheless, HuR knockdown in a fibrosarcoma line caused
reduction of IL-3 UTR reporter levels, and decreased half-
lives of the reporter mRNA [65]. HuR KD in Jurkat cells
prevented activation-induced stabilization of INFg mRNA
and decreased IL-13 mRNA half-life, although it is not estab-
lished whether it occurred directly through the 3′ UTR
[45,66].
However, other experimental evidence suggests that HuR
does not substantially regulate certain cytokine 3′ UTRs. For
example, overexpression of HuR did not stabilize CSF2 and
IL-3 ARE reporters, while a fos ARE reporter was stabilized
[67]. Knockdown of HuR in Jurkat cells produced a very mild
(1.2 fold) destabilizing effect on a IL-3 UTR reporter [58],
likely insufficient to explain the drastic decrease in its mRNA
levels seen in the HuR KO. Studies with IL-2 showed that
HuR overexpression failed to stabilize GFP-IL-2 reporter half-
life, and HuR did not bind to IL-2 mRNA affinity resin [68].
HuR also didn’t bind IL-2 UTR fragments efficiently [39]. An
Figure 5. HuR controls IL-2 production transcriptionally and regulates NFATC1 levels upon activation. (a) Activity of a firefly luciferase reporter under the IL-2 gene
promoter in WT, HuR KO1 and KO2 Jurkat cells under resting and activated conditions, n = 4. Activity was normalized to co-transfected renilla luciferase and
expressed relative to WT activated cells. (b) Representative western blot of NFATC1 levels in resting and activated WT and KO cells. (c) Quantification of NFATC1
protein levels under the above conditions, n = 4. (d) Relative luciferase activity of the NFATC1 3′ UTRs, measured as in Figure 4, n = 3.
RNA BIOLOGY 691
additional report found that HuR binds the IL-2 3′ UTR, but
this binding event does not impact IL-2 mRNA stability [37].
Finally, a transcriptome-wide method to detect HuR-
associated mRNAs in Jurkat cells identified no enrichment
for cytokine gene categories, and showed strong depletion for
IL-2 and IL-3 mRNAs (although some binding of CSF2 and
TNF), and none of the above cytokine mRNAs were enriched
in a RIP-seq study in activated T cells [34,35]. It should be
noted that HuR-bound transcripts as a group do show slower
decay rates upon activation [36]. However, when the role of
HuR in controlling the cytokine UTRs was directly assessed
by comparison of UTR reporter activities in two stable and
tractable WT vs HuR KO cell systems in this study (Figure 4),
no regulation was observed. Thus, HuR does not always lead
to direct stabilization of transcripts containing ARE elements,
and other mechanisms should be investigated. Some of the
above discrepancies likely stem from the differences in the
interrogated cell types.
Instead of regulating the cytokine response through the 3′
UTR in Jurkat cells, the data indicates that HuR exerts broad
control through upstream factors. The coordinated and pro-
found lack of cytokine induction pointed to a transcriptional
response, and the induction of the IL-2 promoter was indeed
strongly impaired in HuR KO cells (Figure 5(a)).
Transcriptional control of the CCL5 chemokine has been
shown to depend on HuR in MCF-7 cells [69]. Induction of
the major cytokine transcription factor NFATC1 was
impaired upon stimulation in HuR KO cells (Figure 5(b,c)),
strongly suggesting that the IL-2 transcriptional response was
abrogated at least in part due to this deficiency. In similarity
to the cytokine mRNA results, 3′ UTR isoforms of NFATC1
were not coherently regulated by HuR (Figure 5(d)), indicat-
ing regulation through other modes. Here, control of splicing
is a likely mechanism, since HuR is found to associate with
intronic sites as much as or more than 3′ UTRs, comprising
30–35% of CLIP sites in HeLa cells, and 40–45% in 293T cells
[24,49]. Additionally, HuR regulates alternative splicing of Fas
pre-mRNA [26]. Interestingly, differential exon usage analysis
of the RNA-seq data indicates that the NFATC1 mRNA
undergoes substantial alternative splicing upon activation in
WT cells (Figure S6, left), and this splicing program is largely
negated (not enacted) in the absence of HuR (Figure S6,
right). Thus, it can be hypothesized that HuR directly affects
alternative splicing of NFATC1 upon activation, with subse-
quent effects on its mRNA and/or protein stability and func-
tion. However, other post-transcriptional modes that do not
involve the UTR, including regulation of target mRNA trans-
lation, cannot be ruled out and require further examination.
Overall, further insight into HuR’s modes of action and tar-
gets of regulation will be gained as additional knockout mod-
els amenable to mechanistic dissection become available, such
as the pancreatic and colon cancer cell lines [57].
Materials and methods
CRISPR/Cas9-mediated generation of HuR KO clones
Knockouts in Jurkat cells were obtained by selection-free
immunoblot screening as previously described [48]. Jurkat
cells were cultured in RPMI1640 media with 10% FBS and
1x penicillin/streptomycin at 37°C with 5% CO2. Three
pSpCas9(BB) plasmids co-expressing Cas9 and sgRNAs tar-
geting the third, fourth, and fifth exons of HuR were inde-
pendently transiently transfected into cells by electroporation
in a 0.4 mL cuvette (300V, infinite resistance, 960 µF capaci-
tance). Clonal populations were grown and screened by dot
immunoblot with anti-HuR antibodies (Santa Cruz
Biotechnology, clone 3A2, sc-5261). HuR KO1 (clone 1A8,
targeting the 5th exon) and HuR KO2 (clone 1F3, targeting the
3rd exon) were validated by western blot. KO cells were
cultured on WT Jurkat-conditioned media to reduce adapta-
tion to the absence of HuR.
Cellular and molecular characterization of KO clones
For confocal microscopy, cells were resuspended in 50 µL
PBS, fixed at room temperature for 20 minutes by addition
of 250 µL 4% PFA in PBS, washed in PBS + 1% BSA, and
permeabilized in 0.3% Triton-X100 in PBS + 1% BSA at r.t.
for 10 minutes. Cells were spun and resuspended in PBS + 1%
BSA, and 50 µL of suspension were labeled with 1 µL of 50 µg/
mL 7AAD (Invitrogen) and 2 µL of 200 U/mL Phalloidin-CF
488A (Biotium) at r.t. for 20 minutes. For RNAseq material
collection and IL-2 production measurements, WT and HuR
KO early-passage cells at a density of 0.5 × 106 cells/mL were
activated with 20 ng/mL PMA + 500 ng/mL ionomycin or left
untreated for 24 hours. Total RNA from cell pellets was
collected with RiboZol. Three biological replicates were per-
formed. RNAseq libraries were produced using the NEBnext
Ultra Directional RNA library prep kit and sequenced on an
Illumina NextSeq instrument. Note that the RNA-seq data
confirms biallelic deletion at the sgRNA-targeted site (Figure
S7), and a 5–7-fold reduction in HuR transcript levels in the
activated and resting states, respectively. Read processing and
R analysis was carried out using the systemPiper [70] work-
flow. Transcriptome and genome alignment was performed
by tophat2/bowtie2 [71,72] to the Gencode v27/GRCh38
annotations. Differential expression analysis was performed
using DESeq2 [73] and DEXSeq [74]. Gene ontology enrich-
ment analyses were carried out using the GOstats [75] and
clusterProfiler [76] packages. The raw and processed RNA-seq
data are deposited in GEO under accession GSE121966. For
IL-2 production measurement, supernatant media after cell
activation were spun down and frozen. IL-2 amounts were
measured by ELISA (R&D Systems Quantikine) using the kit
standard controls. The following antibodies were used in
western blot: HuR (Santa Cruz, clone 3A2), GAPDH
(ThermoFisher, clone 6C5), NFATC1 (Biolegend, clone
7A6), ERK2 (Santa Cruz).
Re-expression of HuR in KO cells
HuR ORF was cloned into a modified retroviral MSCV-PIG
vector (containing an MluI site between XhoI and EcoRI) using
BglII-XhoI. MSCV-PIG (Puro IRES GFP) was a gift from Scott
Lowe (Addgene plasmid # 18751). HuR-encoding retrovirus
(along with empty vector control retrovirus) was produced
using Phoenix-AMPHO packaging cells co-transfected with
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VSVG pseudotyping plasmid. WT and HuR KO1 Jurkat cells
were transduced with the viral media by spinfection at 800 rpm
for 1 hour at r.t. with 8 µg/mL polybrene. Two to three days
later, cells were placed on selection with 4 µg/mL puromycin to
obtain stable integration populations.
Luciferase reporter assays
For 3′ UTR testing, all full-length UTR regions except
NFATC1(long) were cloned into a modified psiCHECK-2
(Promega) vector containing BsmBI sites [49] using Golden
Gate cloning (see Supplementary File 1 for oligonucleotide
sequences). The NFATC1(long) 3′ UTR, which contained
BsmBI sites, was analogously cloned using SapI. First, an
existing SapI site in psiCHECK-2 was altered by site-
directed mutagenesis (NEB, Q5), and SapI sites were intro-
duced into the MCS by a short insert with XhoI/NotI ends.
Luciferase assays in T-REx-293 and derivative HuR KO cells
were performed at 50–70% confluency, transfected with 10 ng
plasmid using Mirus Trans-IT-LT1 as previously described
[49]. Luciferase reporter activity of the 3′ UTR constructs in
Jurkat and derivative HuR KO cells was also measured in a 96
well format. Cell aliquots (100 µL of cells at 0.5 × 106 cells/
mL) were transfected with Trans-IT-LT1 (1 µL of 30 ng/µL of
reporter plasmid, 0.3 µL Trans-IT-LT1, 9 µL Opti-MEM
media). Eighteen hours after transfection, cells were activated
with 20 ng/mL PMA + 500 ng/mL ionomycin or left
untreated, and 24 hours after transfection cells were harvested
and lysed in 10 µL passive lysis buffer. Each biological repli-
cate consisted of three technical replicates (wells). For pro-
moter activity testing, the IL-2 promoter luciferase plasmid
was a gift from Anjana Rao (Addgene plasmid # 12194). Due
to the lower firefly luciferase activity of the plasmid, transfec-
tions were carried out by electroporation of 2.5 × 106 cells in
250 µL of Opti-MEM + 2 µg IL-2 promoter plasmid + 2 µg
renilla luciferase transfection control plasmid (pRL-TK) in
a 0.4 mL cuvette (280V, infinite resistance, 960 µF capaci-
tance). Twenty four hours after transfection, cells were split
into two 100 µL wells, and activated with PMA/ionomycin as
above or left untreated for 6 hours. Cells were lysed in 20 µL
of passive lysis buffer, and 7–15 µL of lysate were assayed with
50 µL of Promega Dual-Luciferase reagents on a Turner 20/20
luminometer with 10 second integration. Averaging and sta-
tistical analysis (two-tailed paired Student’s t-test) were done
after logarithmic transformation. Data in graphs are displayed
in the original scale.
Acknowledgments
I am thankful to the Rasmussen lab for confocal microscopy assistance.
This work was supported by the University of California Cancer
Research Coordinating Committee, Grant ID# CRN-18-524844.
Disclosure statement
No potential conflict of interest was reported by the author.
Funding
This work was supported by the University of California Cancer
Research Coordinating Committee [CRN-18-524844].
References
[1] Katsanou V, Milatos S, Yiakouvaki A, et al. The RNA-binding
protein Elavl1/HuR is essential for placental branching morpho-
genesis and embryonic development. Mol Cell Biol. 2009 May;29
(10):2762–2776. PubMed PMID: 19307312; PubMed Central
PMCID: PMCPMC2682039.
[2] Ghosh M, Aguila HL, Michaud J, et al. Essential role of the
RNA-binding protein HuR in progenitor cell survival in mice.
J Clin Invest. 2009 Dec;119(12):3530–3543. PubMed PMID:
19884656; PubMed Central PMCID: PMCPMC2786787.
[3] Skliris A, Papadaki O, Kafasla P, et al. Neuroprotection requires
the functions of the RNA-binding protein HuR. Cell Death Differ.
2015 May;22(5):703–718. PubMed PMID: 25301069; PubMed
Central PMCID: PMCPMC4392069.
[4] Sun K, Li X, Chen X, et al. Neuron-specific HuR-deficient mice
spontaneously develop motor neuron disease. J Immunol. 2018 Jul
1;201(1):157–166. PubMed PMID: 29760195; PubMed Central
PMCID: PMCPMC6008238.
[5] Chi MN, Auriol J, Jegou B, et al. The RNA-binding protein
ELAVL1/HuR is essential for mouse spermatogenesis, acting
both at meiotic and postmeiotic stages. Mol Biol Cell. 2011 Aug
15;22(16):2875–2885. PubMed PMID: 21737689; PubMed Central
PMCID: PMCPMC3154883.
[6] Abdelmohsen K, Gorospe M. Posttranscriptional regulation of
cancer traits by HuR. Wiley Interdiscip Rev RNA. 2010 Sep-Oct
;1(2):214–229. . PubMed PMID: 21935886; PubMed Central
PMCID: PMCPMC3808850.
[7] Brody JR, Dixon DA. Complex HuR function in pancreatic cancer
cells. Wiley Interdiscip Rev RNA. 2018 May;9(3):e1469. . PubMed
PMID: 29452455; PubMed Central PMCID: PMCPMC6040811.
[8] Papadaki O, Milatos S, Grammenoudi S, et al. Control of thymic
T cell maturation, deletion and egress by the RNA-binding pro-
tein HuR. J Immunol. 2009 Jun 1;182(11):6779–6788. PubMed
PMID: 19454673.
[9] Chen J, Cascio J, Magee JD, et al. Posttranscriptional gene regula-
tion of IL-17 by the RNA-binding protein HuR is required for
initiation of experimental autoimmune encephalomyelitis.
J Immunol. 2013 Dec 1;191(11):5441–5450. PubMed PMID:
24166976; PubMed Central PMCID: PMCPMC3831112.
[10] Techasintana P, Ellis JS, Glascock J, et al. The RNA-binding
protein HuR posttranscriptionally regulates IL-2 homeostasis
and CD4(+) Th2 differentiation. Immunohorizons. 2017 Aug 1;1
(6):109–123. PubMed PMID: 30035254; PubMed Central PMCID:
PMCPMC6052877.
[11] Chen J, Martindale JL, Cramer C, et al. The RNA-binding protein
HuR contributes to neuroinflammation by promoting
C-C chemokine receptor 6 (CCR6) expression on Th17 cells.
J Biol Chem. 2017 Sep 1;292(35):14532–14543. PubMed PMID:
28684423; PubMed Central PMCID: PMCPMC5582845.
[12] Diaz-Munoz MD, Bell SE, Fairfax K, et al. The RNA-binding
protein HuR is essential for the B cell antibody response. Nat
Immunol. 2015 Apr;16(4):415–425. PubMed PMID: 25706746;
PubMed Central PMCID: PMCPMC4479220.
[13] DeMicco A, Naradikian MS, Sindhava VJ, et al. B Cell-Intrinsic
Expression of the HuR RNA-Binding Protein Is Required for the
T Cell-Dependent Immune Response In Vivo. J Immunol. 2015
Oct 1;195(7):3449–3462. PubMed PMID: 26320247; PubMed
Central PMCID: PMCPMC4575876.
[14] Katsanou V, Papadaki O, Milatos S, et al. HuR as a negative
posttranscriptional modulator in inflammation. Mol Cell. 2005
Sep 16;19(6):777–789. PubMed PMID: 16168373.
[15] Yiakouvaki A, Dimitriou M, Karakasiliotis I, et al. Myeloid cell
expression of the RNA-binding protein HuR protects mice from
RNA BIOLOGY 693
pathologic inflammation and colorectal carcinogenesis. J Clin
Invest. 2012 Jan;122(1):48–61. PubMed PMID: 22201685;
PubMed Central PMCID: PMCPMC3248801.
[16] Macian F, Lopez-Rodriguez C, Rao A. Partners in transcription:
NFAT and AP-1. Oncogene. 2001 Apr 30;20(19):2476–2489. .
PubMed PMID: 11402342.
[17] Graef IA, Chen F, Crabtree GR. NFAT signaling in vertebrate
development. Curr Opin Genet Dev. 2001 Oct;11(5):505–512.
PubMed PMID: 11532391.
[18] Lindstein T, June CH, Ledbetter JA, et al. Regulation of lympho-
kine messenger RNA stability by a surface-mediated T cell activa-
tion pathway. Science. 1989 Apr 21;244(4902):339–343. PubMed
PMID: 2540528.
[19] Chen CY, Shyu AB. AU-rich elements: characterization and
importance in mRNA degradation. Trends Biochem Sci. 1995
Nov;20(11):465–470. PubMed PMID: 8578590.
[20] Vlasova-St Louis I, Bohjanen PR. Post-transcriptional regulation
of cytokine signaling by AU-rich and GU-rich elements.
J Interferon Cytokine Res. 2014 Apr;34(4):233–241. . PubMed
PMID: 24697201; PubMed Central PMCID: PMCPMC3976587.
[21] Meisner NC, Filipowicz W. Properties of the regulatory
RNA-binding protein hur and its role in controlling miRNA
repression. Adv Exp Med Biol. 2011;700:106–123. . PubMed
PMID: 21755477.
[22] Brennan CM, Steitz JA. HuR and mRNA stability. Cell Mol Life
Sci. 2001 Feb;58(2):266–277. 10.1007/PL00000854. PubMed
PMID: 11289308.
[23] Gubin MM, Techasintana P, Magee JD, et al. Conditional knock-
out of the RNA-binding protein HuR in CD4(+) T cells reveals
a gene dosage effect on cytokine production. Mol Med. 2014
Mar;20(20):93–108. . PubMed PMID: 24477678; PubMed
Central PMCID: PMCPMC3960399.
[24] Lebedeva S, Jens M, Theil K, et al. Transcriptome-wide analysis of
regulatory interactions of the RNA-binding protein HuR. Mol
Cell. 2011 Aug 5;43(3):340–352. PubMed PMID: 21723171.
[25] Mukherjee N, Corcoran DL, Nusbaum JD, et al. Integrative reg-
ulatory mapping indicates that the RNA-binding protein HuR
couples pre-mRNA processing and mRNA stability. Mol Cell.
2011 Aug 5;43(3):327–339. PubMed PMID: 21723170; PubMed
Central PMCID: PMCPMC3220597.
[26] Izquierdo JM. Hu antigen R (HuR) functions as an alternative
pre-mRNA splicing regulator of Fas apoptosis-promoting receptor
on exon definition. J Biol Chem. 2008 Jul 4;283(27):19077–19084.
. PubMed PMID: 18463097.
[27] Chang SH, Elemento O, Zhang J, et al. ELAVL1 regulates alter-
native splicing of eIF4E transporter to promote postnatal
angiogenesis. Proc Natl Acad Sci U S A. 2014 Dec 23;111
(51):18309–18314. PubMed PMID: 25422430; PubMed Central
PMCID: PMCPMC4280608.
[28] Mazan-Mamczarz K, Galban S, Lopez de Silanes I, et al. RNA-
binding protein HuR enhances p53 translation in response to
ultraviolet light irradiation. Proc Natl Acad Sci U S A. 2003 Jul
8;100(14):8354–8359. PubMed PMID: 12821781; PubMed Central
PMCID: PMCPMC166233.
[29] Kullmann M, Gopfert U, Siewe B, et al. ELAV/Hu proteins inhibit
p27 translation via an IRES element in the p27 5ʹUTR. Genes Dev.
2002 Dec 1;16(23):3087–3099. PubMed PMID: 12464637;
PubMed Central PMCID: PMCPMC187493.
[30] Kawai T, Lal A, Yang X, et al. Translational control of cytochrome
c by RNA-binding proteins TIA-1 and HuR. Mol Cell Biol. 2006
Apr;26(8):3295–3307. PubMed PMID: 16581801; PubMed Central
PMCID: PMCPMC1446930.
[31] Lal A, Kawai T, Yang X, et al. Antiapoptotic function of
RNA-binding protein HuR effected through prothymosin alpha.
Embo J. 2005 May 18;24(10):1852–1862. PubMed PMID:
15861128; PubMed Central PMCID: PMCPMC1142594.
[32] Zhu H, Zhou HL, Hasman RA, et al. Hu proteins regulate poly-
adenylation by blocking sites containing U-rich sequences. J Biol
Chem. 2007 Jan 26;282(4):2203–2210. PubMed PMID: 17127772.
[33] Dai W, Zhang G, Makeyev EV. RNA-binding protein HuR auto-
regulates its expression by promoting alternative polyadenylation
site usage. Nucleic Acids Res. 2012 Jan;40(2):787–800. . PubMed
PMID: 21948791; PubMed Central PMCID: PMCPMC3258158.
[34] Mukherjee N, Lager PJ, Friedersdorf MB, et al. Coordinated
posttranscriptional mRNA population dynamics during T-cell
activation. Mol Syst Biol. 2009;5:288. .PubMed PMID: 19638969;
PubMed Central PMCID: PMCPMC2724974.
[35] Techasintana P, Davis JW, Gubin MM, et al. Transcriptomic-wide
discovery of direct and indirect HuR RNA targets in activated
CD4+ T cells. PLoS One. 2015;10(7):e0129321. . PubMed PMID:
26162078; PubMed Central PMCID: PMCPMC4498740.
[36] Blackinton JG, Keene JD. Functional coordination and
HuR-mediated regulation of mRNA stability during T cell
activation. Nucleic Acids Res. 2016 Jan 8;44(1):426–436. . PubMed
PMID: 26490963; PubMed Central PMCID: PMCPMC4705648.
[37] Seko Y, Azmi H, Fariss R, et al. Selective cytoplasmic translocation
of HuR and site-specific binding to the interleukin-2 mRNA are
not sufficient for CD28-mediated stabilization of the mRNA.
J Biol Chem. 2004 Aug 6;279(32):33359–33367. PubMed PMID:
15020598.
[38] Ma WJ, Cheng S, Campbell C, et al. Cloning and characterization
of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem.
1996 Apr 5;271(14):8144–8151. PubMed PMID: 8626503.
[39] Raghavan A, Robison RL, McNabb J, et al. HuA and tristetrapro-
lin are induced following T cell activation and display distinct but
overlapping RNA binding specificities. J Biol Chem. 2001 Dec
21;276(51):47958–47965. PubMed PMID: 11602610.
[40] Vakalopoulou E, Schaack J, Shenk T. A 32-kilodalton protein
binds to AU-rich domains in the 3ʹ untranslated regions of rapidly
degraded mRNAs. Mol Cell Biol. 1991 Jun;11(6):3355–3364.
PubMed PMID: 1903842; PubMed Central PMCID:
PMCPMC360189.
[41] Myer VE, Fan XC, Steitz JA. Identification of HuR as a protein
implicated in AUUUA-mediated mRNA decay. Embo J. 1997 Apr
15;16(8):2130–2139. . PubMed PMID: 9155038; PubMed Central
PMCID: PMCPMC1169815.
[42] Ford LP, Watson J, Keene JD, et al. ELAV proteins stabilize dead-
enylated intermediates in a novel in vitro mRNA deadenylation/
degradation system. Genes Dev. 1999 Jan 15;13(2):188–201. PubMed
PMID: 9925643; PubMed Central PMCID: PMCPMC316394.
[43] Dean JL, Wait R, Mahtani KR, et al. The 3ʹ untranslated region of
tumor necrosis factor alpha mRNA is a target of the mRNA-
stabilizing factor HuR. Mol Cell Biol. 2001 Feb;21(3):721–730.
PubMed PMID: 11154260; PubMed Central PMCID:
PMCPMC86664.
[44] Casolaro V, Fang X, Tancowny B, et al. Posttranscriptional reg-
ulation of IL-13 in T cells: role of the RNA-binding protein HuR.
J Allergy Clin Immunol. 2008 Apr;121(4):853–9 e4. PubMed
PMID: 18279945; PubMed Central PMCID: PMCPMC2666917.
[45] Wang JG, Collinge M, Ramgolam V, et al. LFA-1-dependent HuR
nuclear export and cytokine mRNA stabilization in T cell
activation. J Immunol. 2006 Feb 15;176(4):2105–2113. PubMed
PMID: 16455966.
[46] Fan XC, Steitz JA. Overexpression of HuR, a nuclear-cytoplasmic
shuttling protein, increases the in vivo stability of ARE-containing
mRNAs. Embo J. 1998 Jun 15;17(12):3448–3460. . PubMed PMID:
9628880; PubMed Central PMCID: PMCPMC1170681.
[47] Ming XF, Stoecklin G, Lu M, et al. Parallel and independent
regulation of interleukin-3 mRNA turnover by phosphatidylino-
sitol 3-kinase and p38 mitogen-activated protein kinase. Mol Cell
Biol. 2001 Sep;21(17):5778–5789. PubMed PMID: 11486017;
PubMed Central PMCID: PMCPMC87297.
[48] Estep JA, Sternburg EL, Sanchez GA, et al. Immunoblot screening
of CRISPR/Cas9-mediated gene knockouts without selection. BMC
Mol Biol. 2016 Apr 2;17:9. 10.1186/s12867-016-0061-0. PubMed
PMID: 27038923; PubMed Central PMCID: PMCPMC4818936.
[49] Li Y, Estep JA, Karginov FV. Transcriptome-wide identification
and validation of interactions between the miRNA machinery and
694 F. V. KARGINOV
HuR on mRNA targets. J Mol Biol. 2018 Feb 2;430(3):285–296.
PubMed PMID: 29273203.
[50] Liao W, Lin JX, Leonard WJ. Interleukin-2 at the crossroads of
effector responses, tolerance, and immunotherapy. Immunity.
2013 Jan 24;38(1):13–25. PubMed PMID: 23352221; PubMed
Central PMCID: PMCPMC3610532.
[51] Macian F, Garcia-Rodriguez C, Rao A. Gene expression elicited by
NFAT in the presence or absence of cooperative recruitment of
Fos and Jun. Embo J. 2000 Sep 1;19(17):4783–4795. PubMed
PMID: 10970869; PubMed Central PMCID: PMCPMC302068.
[52] Kim HS, Wilce MC, Yoga YM, et al. Different modes of interac-
tion by TIAR and HuR with target RNA and DNA. Nucleic Acids
Res. 2011 Feb;39(3):1117–1130. PubMed PMID: 21233170;
PubMed Central PMCID: PMCPMC3035456.
[53] Muller MR, Rao A. NFAT, immunity and cancer: a transcription
factor comes of age. Nat Rev Immunol. 2010 Sep;10(9):645–656.
PubMed PMID: 20725108.
[54] Macian F. NFAT proteins: key regulators of T-cell development
and function. Nat Rev Immunol. 2005 Jun;5(6):472–484. PubMed
PMID: 15928679.
[55] Abdelmohsen K, Lal A, Kim HH, et al. Posttranscriptional orches-
tration of an anti-apoptotic program by HuR. Cell Cycle. 2007 Jun
1;6(11):1288–1292. PubMed PMID: 17534146.
[56] Jimbo M, Blanco FF, Huang YH, et al. Targeting the
mRNA-binding protein HuR impairs malignant characteristics
of pancreatic ductal adenocarcinoma cells. Oncotarget. 2015 Sep
29;6(29):27312–27331. PubMed PMID: 26314962; PubMed
Central PMCID: PMCPMC4694992.
[57] Lal S, Cheung EC, Zarei M, et al. CRISPR knockout of the
HuR gene causes a xenograft lethal phenotype. Mol Cancer
Res. 2017 Jun;15(6):696–707. 10.1158/1541-7786.MCR-16-
0361. PubMed PMID: 28242812; PubMed Central PMCID:
PMCPMC5466444.
[58] Gonzalez-Feliciano JA, Hernandez-Perez M, Estrella LA, et al. The
role of HuR in the post-transcriptional regulation of interleukin-3
in T cells. PLoS One. 2014;9(3):e92457. . PubMed PMID:
24658545; PubMed Central PMCID: PMCPMC3962401.
[59] Meisner NC, Hackermuller J, Uhl V, et al. mRNA openers and
closers: modulating AU-rich element-controlled mRNA stability by
a molecular switch in mRNA secondary structure. Chembiochem.
2004 Oct 4;5(10):1432–1447. PubMed PMID: 15457527.
[60] Ramgolam VS, DeGregorio SD, Rao GK, et al. T cell LFA-1
engagement induces HuR-dependent cytokine mRNA stabiliza-
tion through a Vav-1, Rac1/2, p38MAPK and MKK3 signaling
cascade. PLoS One. 2010 Dec 29;5(12):e14450. PubMed PMID:
21206905; PubMed Central PMCID: PMCPMC3012057.
[61] Peng SS, Chen CY, Xu N, et al. RNA stabilization by the AU-rich
element binding protein, HuR, an ELAV protein. Embo J. 1998
Jun 15;17(12):3461–3470. PubMed PMID: 9628881; PubMed
Central PMCID: PMCPMC1170682.
[62] Levy NS, Chung S, Furneaux H, et al. Hypoxic stabilization of
vascular endothelial growth factor mRNA by the RNA-binding
protein HuR. J Biol Chem. 1998 Mar 13;273(11):6417–6423.
PubMed PMID: 9497373.
[63] Wang W, Furneaux H, Cheng H, et al. HuR regulates p21 mRNA
stabilization by UV light. Mol Cell Biol. 2000 Feb;20(3):760–769.
PubMed PMID: 10629032; PubMed Central PMCID:
PMCPMC85192.
[64] Wang W, Caldwell MC, Lin S, et al. HuR regulates cyclin A and
cyclin B1 mRNA stability during cell proliferation. Embo J. 2000
May 15;19(10):2340–2350. PubMed PMID: 10811625; PubMed
Central PMCID: PMCPMC384372.
[65] Raineri I, Wegmueller D, Gross B, et al. Roles of AUF1 isoforms,
HuR and BRF1 in ARE-dependent mRNA turnover studied by
RNA interference. Nucleic Acids Res. 2004;32(4):1279–1288. .
PubMed PMID: 14976220; PubMed Central PMCID:
PMCPMC390274.
[66] Stellato C, Gubin MM, Magee JD, et al. Coordinate regulation of
GATA-3 and Th2 cytokine gene expression by the RNA-binding
protein HuR. J Immunol. 2011 Jul 1;187(1):441–449. PubMed
PMID: 21613615; PubMed Central PMCID: PMCPMC5801757.
[67] Chen CY, Xu N, Shyu AB. Highly selective actions of HuR in
antagonizing AU-rich element-mediated mRNA destabilization.
Mol Cell Biol. 2002 Oct;22(20):7268–7278. PubMed PMID:
12242302; PubMed Central PMCID: PMCPMC139819.
[68] Shim J, Lim H, Yates JR, et al. Nuclear export of NF90 is required
for interleukin-2 mRNA stabilization. Mol Cell. 2002 Dec;10
(6):1331–1344. PubMed PMID: 12504009.
[69] Brauss TF, Winslow S, Lampe S, et al. The RNA-binding protein
HuR inhibits expression of CCL5 and limits recruitment of
macrophages into tumors. Mol Carcinog. 2017 Dec;56
(12):2620–2629. PubMed PMID: 28731284.
[70] Backman TWH, Girke T. systemPipeR: NGS workflow and report
generation environment. BMC Bioinformatics. 2016 Sep
20;17:388. 10.1186/s12859-016-1241-0. PubMed PMID:
27650223; PubMed Central PMCID: PMCPMC5029110.
[71] Kim D, Pertea G, Trapnell C, et al. TopHat2: accurate alignment
of transcriptomes in the presence of insertions, deletions and gene
fusions. Genome Biol. 2013 Apr 25;14(4):R36. PubMed PMID:
23618408; PubMed Central PMCID: PMCPMC4053844.
[72] Langmead B, Salzberg SL. Fast gapped-read alignment with
Bowtie 2. Nat Methods. 2012 Mar 4;9(4):357–359. . PubMed
PMID: 22388286; PubMed Central PMCID: PMCPMC3322381.
[73] Love MI, Huber W, Anders S. Moderated estimation of fold
change and dispersion for RNA-seq data with DESeq2. Genome
Biol. 2014;15(12):550. . PubMed PMID: 25516281; PubMed
Central PMCID: PMCPMC4302049.
[74] Anders S, Reyes A, Huber W. Detecting differential usage of exons
from RNA-seq data. Genome Res. 2012 Oct;22(10):2008–2017. .
PubMed PMID: 22722343; PubMed Central PMCID:
PMCPMC3460195.
[75] Falcon S, Gentleman R. Using GOstats to test gene lists for GO
term association. Bioinformatics. 2007 Jan 15;23(2):257–258. .
PubMed PMID: 17098774.
[76] Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for
comparing biological themes among gene clusters. OMICS. 2012
May;16(5):284–287. PubMed PMID: 22455463; PubMed Central
PMCID: PMCPMC3339379.
RNA BIOLOGY 695
